Literature DB >> 18039071

Neurobehavioral impact of menopause on mood.

Jeanne Leventhal Alexander1, Lorraine Dennerstein, Nancy Fugate Woods, Krista Kotz, Uriel Halbreich, Vivien Burt, Gregg Richardson.   

Abstract

The menopausal transition is a time of risk for mood change ranging from distress to minor depression to major depressive disorder in a vulnerable subpopulation of women in the menopausal transition. Somatic symptoms have been implicated as a risk factor for mood problems, although these mood problems have also been shown to occur independently of somatic symptoms. Mood problems have been found to increase in those with a history of mood continuum disorders, but can also occur de novo as a consequence of the transition. Stress has been implicated in the etiology and the exacerbation of these mood problems. Estrogen and add-back testosterone have both been shown to positively affect mood and well-being. In most cases, the period of vulnerability to mood problems subsides when the woman's hormonal levels stabilize and she enters full menopause.

Entities:  

Mesh:

Year:  2007        PMID: 18039071     DOI: 10.1586/14737175.7.11s.S81

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  14 in total

1.  Does family history of depression predict major depression in midlife women? Study of Women's Health Across the Nation Mental Health Study (SWAN MHS).

Authors:  Alicia Colvin; Gale A Richardson; Jill M Cyranowski; Ada Youk; Joyce T Bromberger
Journal:  Arch Womens Ment Health       Date:  2014-06-21       Impact factor: 3.633

2.  The role of family history of depression and the menopausal transition in the development of major depression in midlife women: Study of women's health across the nation mental health study (SWAN MHS).

Authors:  Alicia Colvin; Gale A Richardson; Jill M Cyranowski; Ada Youk; Joyce T Bromberger
Journal:  Depress Anxiety       Date:  2017-05-10       Impact factor: 6.505

3.  The antidepressant-like effect of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane involves a regulation of β-type estrogen receptors.

Authors:  Julie Espallergues; Jamal Temsamani; Claude Laruelle; Alexandre Urani; Tangui Maurice
Journal:  Psychopharmacology (Berl)       Date:  2010-10-28       Impact factor: 4.530

4.  Depressive symptoms associated with physical health problems in midlife women: A longitudinal study.

Authors:  Holly J Jones; Pamela A Minarik; Catherine L Gilliss; Kathryn A Lee
Journal:  J Affect Disord       Date:  2019-12-02       Impact factor: 4.839

5.  Association between resting-state EEG oscillation and psychometric properties in perimenopausal women.

Authors:  Ren-Jen Hwang; Hsiu-Chin Hsu; Lee-Fen Ni; Hsin-Ju Chen; Yu-Sheun Lee; Yueh-O Chuang
Journal:  BMC Womens Health       Date:  2022-05-10       Impact factor: 2.742

6.  Resveratrol ameliorates estrogen deficiency-induced depression- and anxiety-like behaviors and hippocampal inflammation in mice.

Authors:  Tianyao Liu; Yuanyuan Ma; Ruiyu Zhang; Hongyu Zhong; Lian Wang; Jinghui Zhao; Ling Yang; Xiaotang Fan
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

7.  Ovariectomy results in inbred strain-specific increases in anxiety-like behavior in mice.

Authors:  Sarah Adams Schoenrock; Daniel Oreper; Nancy Young; Robin Betsch Ervin; Molly A Bogue; William Valdar; Lisa M Tarantino
Journal:  Physiol Behav       Date:  2016-09-29

8.  Temporal associations of hot flashes and depression in the transition to menopause.

Authors:  Ellen W Freeman; Mary D Sammel; Hui Lin
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

9.  Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling.

Authors:  Qian Li; Nicole R Sullivan; Carrie E McAllister; Louis D Van de Kar; Nancy A Muma
Journal:  Psychoneuroendocrinology       Date:  2012-12-05       Impact factor: 4.905

10.  Nociceptive and anxiety-like behavior in reproductively competent and reproductively senescent middle-aged rats.

Authors:  Alicia A Walf; Jason J Paris; Cheryl A Frye
Journal:  Gend Med       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.